Healthcare  Name:  Sector:  Chief Executive: MedImmune Healthcare David Mott  Summary: Develops and markets products that address medical needs in areas such as infectious disease, immune regulation and cancer.  Stage of Initial  Investment: Venture  Liquidity: IPO (NASDAQ: MEDI) One MedImmune Way Gaithersburg, MD 20878 Phone: 301.398.0000
	Copyright ©2007 Rho Capital Partners, Inc.